Please wait...
About This Project
70% of breast cancers are estrogen receptor α (ERα)-positive. ERα is the antenna that senses the ovarian hormone estrogen (E2) and drives tumour cell proliferation and spreading. 4OH-tamoxifen and faslodex are given to patients to prevent cancer growth and spreading but they possess serious side effects. Thus, additional drugs are needed to fight breast cancer. We will explore existing drugs for the possibility of ‘reuse’ as breast cancer drugs.
More Lab Notes From This Project
Browse Other Projects on Experiment
Related Projects
Saving lives with synthetic antivenoms: looking for novel solutions to Lonomia envenoming in Colombia
Venomous caterpillars of the genus Lonomia cause deadly accidents in Colombia. In Brazil it is estimated...
Can immune cells prevent 3D printed blood vessels from falling apart?
Mass production of cells is limited by nutrient delivery. 3D printing of hydrogel has enabled the printing...
The Health Justice Project: Using digital stories to address health disparities as a social justice issue
The purpose of this project is to examine the link between racial and social injustice based on one's minority...